fda glp-1 news november 2025 Pipeline Update: August - Prime Therapeutics FDA Accepts NDA Submission for

for research use only Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) studied for its potential role in somatotropic signaling, visceral adipose tissue metabolism, and GH/IGF-1 axis modulation

What parents, educators, and coaches need to know about GLP-1s and how these drugs may impact your young athlete.

At low doses, GLP-1 agonists have been observed to reduce alcohol cravings, lower the frequency and volume of drinking and in some individuals produce a natural disinterest in alcohol altogether

Here's what to know about the contagious virus and how best to prevent an infection.

GLP-1 Drugs GLP-1 Drugs GLP-1 Drugs Distribution GLP-1 Drugs Distribution Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target indication and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering

Understanding what to expect helps you distinguish normal adaptation from side effects requiring medical attention